References
- CALDWELL, J., GARDNER, I. and SWALES, N., 1995, An introduction to drug disposition: the basic principles of absorption, distribution, metabolism, and excretion, Toxicology and Pathology, 23, 102–114.
- CAVANAGH, B. and CHEN, F. C.-K., 1968, The experimental neuropathy in rats caused by p-bromophenylacetylurea. Journal of Neurosurgery and Psychiatry, 31, 471–478.
- CHEN, F. C.-K. and CAVANAGH, L. B., 1971, Factors affecting neurotoxicity by p-bromophenylacetylurea in rats. British Journal of Experimental Pathology, 52, 315–321.
- DIEZEL, B. and QUADBECK, G., 1960, Nervenschadigung durch p-bromphenylacetylharnstoff, Naunyn. Schmiedeberg's Archives and Experimental Pharmakologie and Pathology, 238, 534–541.
- GIBALDI, M. and PERRIER, D. 1982, Pharmacokinetics, 2nd edn (New York: Marcel Dekker).
- JAKOBSEN, J., LAMBERT, E. H., CARLSON, G. and BRIMHOIN, 5, 1982, Clinical and electrophysiological characteristics of the experimental neuropathy caused by p-bromophenylacetylurea. Experimental Neurology, 75, 158–172.
- JORTNER, S., DYER, K., WALTON, A. and EHRICH, M., 1997, Synaptophysin immunoreactive axonal swelling in p-bromophenylacetylurea -induced neuropathy. Neurotoxicology,, 18, 161–168.
- MARTIN, B. K., 1986, Pharmacokinetics. In H. Glenny and P. Neknes (eds), Handbook of Clinical Drug Research (London: Blackwell), pp. 59–93.
- MEAD, R. and CURNOW, R. N., 1987, Statistical Methods in Agriculture and Experimental Biology (London: Chapman & Hall).
- NAGATA, H. and BRIMHOIN, S., 1986, Neurotoxicity of halogenated phenylacetylureas is linked to abnormal onset of rapid axonal transport. Brain Research, 385, 136–142.
- NAGATA, H., BRIMIJOIN, S., LOW, P. and SCHMELZER, J. D., 1987, Slow axonal transport in experimental hypoxia and in neuropathy induced by p-bromophenylacetylurea. Brain Research, 422, 319–326.
- OKA, N. and BRIMIJOIN, 5., 1990, Premature onset of fast axonal transport in bromophenylacetylurea neuropathy: an electrophoretic analysis of proteins exported into motor nerve. Brain Research, 509, 107–110.
- PARKINSON, A., 1996, Biotransformation of xenobiotics. In C. D. Klaassen (ed.), Casarett & Doull's Toxicology: The Basic Science of Poisons (New York: McGraw-Hill, Inc.), pp. 113-186.
- TRONCOSO, J. C., CarFFIN, J. W., PRICE, D. L. and HESS -Kozww, K. M., 1982, Pathology of the peripheral neuropathy induced by p-bromophenylacetylurea. Laboratory Investigation, 46, 215–223.
- Xu, J., LAMB, J., DUKES, R., PURCELL, W. M. and RAY, D. E., 1999a, Application of the high-performance liquid chromatographic method for separation, purification and characterisation of p-bromophenylacetylurea and its metabolites. Journal of Chromatography B, 732, 349–356.
- Xu, J., LISTER, T., PURCELL, W. M. and RAY, D. E., 1999b, Neurotoxic potentiation is related to a metabolic interaction between p-bromophenylacetylurea and phenylmethanesulfonyl fluoride. Toxicology and Applied Pharmacology, 157, 222–226.